RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • CBER Releases Strategic Plan for 2012-2016 Period

    The US Food and Drug Administration's (FDA) biologics regulatory body, the Center for Biologics Research and Evaluation, has released its strategic regulatory plan for the upcoming five years. The plan, " Strategic Plan for Regulatory Science and Research ," was released 10 May 2012 and explores how the center plans to "provide the environment to facilitate the development of new biological products and evaluate them for safety and effectiveness." CBER's plan outlines s...